Amgen Says Enbrel Protected By Legit Patents, Rulings
By Bryan Koenig · January 9, 2025, 8:44 PM EST
Amgen has asked a Virginia federal judge to permanently toss the latest version of a proposed class action accusing it of illegally entrenching and expanding patent rights to stave off cheaper...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login